Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
NEWHALL CHARLES W III
Director at SUPERNUS PHARMACEUTICALS. Filing since 4 May 2012.
CIK 0001005544
Company
Date
Role
Action
Shares
Amount
Of holding
SUPN
SUPERNUS PHARMACEUTICALS, INC.
9 Oct 2025
Director
Sold on a plan
25,000
$1.27M
19.3%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
27 Aug 2025
Director
Sold on a plan
3,588
$161.50K
2.7%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
25 Aug 2025
Director
Sold on a plan
1,000
$45.00K
0.7%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
22 Aug 2025
Director
Sold on a plan
1,412
$63.54K
1.0%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
11 Nov 2024
Director
Sold at will
10,700
$387.77K
7.6%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
16 Nov 2023
Director
Sold at will
2,500
$70.03K
2.1%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
4 May 2012
Director
Bought
4,400,000
$22.00M
70.5%
7 decisions on file.
